CSIGN COVID surveillance intensification in Ghana Network
- Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
- Total publications:20 publications
Grant number: RIA2020EF-2983
Grant search
Key facts
Disease
COVID-19start year
2020Known Financial Commitments (USD)
$594,426.42Funder
European & Developing Countries Clinical Trials Partnership (EDCTP)Principal Investigator
Dr. Michael MarksResearch Location
GhanaLead Research Institution
London School of Hygiene & Tropical MedicineResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease transmission dynamics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The CSIGN project (RIA2020EF-2983) aims to build the Ghana COVID-19 surveillance and response system, by amplifying and redirecting the already excellent influenza surveillance toward the new pathogen, by enhancing response activities through contact tracing, and by building capacity in laboratory testing and sequencing.
Publicationslinked via Europe PMC
Last Updated:5 days ago
View all publications at Europe PMC